Here is some news of note for the week:
> McKesson has relaunched its biopharmaceutical services business. Release
> The EMA says it may seek to order fluoroquinolone and quinolone antibiotics off the market following a review of disabling and potentially long-lasting side effects. Announcement
> Vetter is expanding its secondary packaging operations, adding a second building to its Ravensburg site which will be ready in 2020. Release